Agilent Technologies IncChange company Symbol lookupSelect an option...A Agilent Technologies IncPYR Pyrogenesis Canada IncCHRA Charah Solutions IncFTIIU Futuretech II Acquisition CorpJBL Jabil IncAZO Autozone IncSBFFF SBM Offshore NVALHC Alignment Healthcare IncPRGS Progress Software CorpPMD Psychemedics CorpGo
Change company Symbol lookup
Select an option...
A Agilent Technologies Inc
PYR Pyrogenesis Canada Inc
CHRA Charah Solutions Inc
FTIIU Futuretech II Acquisition Corp
JBL Jabil Inc
AZO Autozone Inc
SBFFF SBM Offshore NV
ALHC Alignment Healthcare Inc
PRGS Progress Software Corp
PMD Psychemedics Corp
Health Care : Life Sciences Tools & Services | Large Cap Growth
Company profileAgilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.
|
|
|
|
| |
| Latest Earnings Beat Consensus (Q1 ending 01/2023) | Next Earnings Announcement | ||||||
|---|---|---|---|---|---|---|---|
| Q1 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced February 28, 2023 | $1.37 | Q1 Consensus of 13 analysts | $1.30 | Difference from consensus | 5.06% | Q2 Earnings will announce | (Unconfirmed) May 22, 2023 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
A's fiscal year ends in October
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.